Restaging patients with N2 (stage IIIa) non–small cell lung cancer after neoadjuvant chemoradiotherapy: A prospective study
- 1 June 2006
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 131 (6) , 1229-1235
- https://doi.org/10.1016/j.jtcvs.2005.08.070
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Improving the Inaccuracies of Clinical Staging of Patients with NSCLC: A Prospective TrialThe Annals of Thoracic Surgery, 2005
- Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography and Computed Tomography ScansThe Annals of Thoracic Surgery, 2005
- Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2004
- The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancerThe Annals of Thoracic Surgery, 2004
- Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomographyThe Annals of Thoracic Surgery, 2004
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Mediastinal restaging: EUS-FNA offers a new perspectiveLung Cancer, 2003
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient managementThorax, 2002
- Endosonographic features predictive of lymph node metastasisGastrointestinal Endoscopy, 1994